-+ 0.00%
-+ 0.00%
-+ 0.00%

Pyxis Oncology Holds Special Stockholder Meeting

PUBT·11/13/2026 21:20:25
Pyxis Oncology Holds Special Stockholder Meeting
  • Pyxis Oncology shareholders approved increasing authorized common stock from 190,000,000 to 380,000,000 shares at the November 13, 2026, special meeting.
  • The charter amendment took effect upon filing on November 13, 2026.
  • Shareholders also authorized adjournments to solicit additional proxies if needed, but no adjournment was necessary because the share increase received sufficient support.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-460698), on November 13, 2026, and is solely responsible for the information contained therein.